Clin2
NCT06964620Likely a fitRecruiting

Sanggua Tablets for prediabetes and mild type 2 diabetes

Diabetes Mellitus, Type 2Impaired Glucose Tolerance

Part of Hormones & metabolism clinical trials.

This trial tests whether Sanggua Tablets, an herbal medicine, can help people with prediabetes or mild type 2 diabetes improve their blood sugar control without needing other medications.

Summary written for real people, not researchers, by Clin2.

Phase
Early Phase 1
Enrollment
84 people
Ages
18 years to 70 years
Study type
Interventional

Who can take part

  • You are between 18 and 70 years old.
  • You have prediabetes (impaired glucose tolerance) or mild type 2 diabetes that does not require medication.
  • Your recent A1c test result is between 5.6% and 7.5%.
  • You have not taken any diabetes or cholesterol medicines in the past 3 months.
  • You do not have serious kidney, heart, liver, lung, or blood disorders, or uncontrolled infections.
  • You are not pregnant, planning to become pregnant, or breastfeeding.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06575478Recruiting· Phase 2
Herbal granules for new type 2 diabetes patients

This study tests two herbal granules (Fuling Yunhua and Dihuang Baoyuan) to see if they help control blood sugar in people with type 2 diabetes who have not yet taken diabetes medication. You will be randomly assigned to one of the granules or a placebo for several weeks, and your blood sugar will be monitored closely.

Beijing
NCT02969798Recruiting
Study of prediabetes with abnormal sugars and medicines

This study looks at adults with prediabetes—specifically abnormal fasting and/or 2-hour blood sugar tests—to see whether a treatment helps improve sugar control. You may also be compared with people who have normal blood sugar (the control group).

San Antonio, Texas
NCT06047262Recruiting· Phase 2
Testing dapansutrile for type 2 diabetes and related problems

This trial tests if a drug called dapansutrile can help control blood sugar and reduce inflammation in people with type 2 diabetes. It may also help prevent or manage diabetes-related complications.

Liège
NCT07668388Recruiting· Phase 2
Testing different doses of UBT251 for type 2 diabetes

This trial tests a new medicine, UBT251, to see how well it lowers blood sugar in people with type 2 diabetes. It compares different doses to find the best one for you.

Birmingham, Alabama
NCT07082114Recruiting· Phase 3
Testing a new tablet for type 2 diabetes

This study tests a new pill called HDM1002 for adults with type 2 diabetes. It aims to see if it helps control blood sugar when added to your current metformin treatment.

Yueyang, Hunan
NCT07755150Not yet recruiting· Phase 2
Study of a new tablet for type 2 diabetes

This study tests an experimental tablet to see if it can help control blood sugar in people with type 2 diabetes. It may be an option for those who are already on metformin or managing with diet and exercise.

Beijing

Hear when a new Impaired Glucose Tolerance trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.